Search

Panacea Biotec

Sector: Healthcare | Industry: Drugs & Pharma
R 219.15 -4.45  | -1.99% -10.13% - 1,329.75
NSE Price: Sep 19, 15:59 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
NSE Sep 19, 15:59 219.15 -4.45 -1.99% 225.90 223.60 32,645 217.80 - 225.90
BSE Sep 19, 2018 217.10 -6.80 -3.04% 220.80 223.90 8,160 216.00 - 226.15
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
SUBSCRIBE TO THE VALUE RESEARCH STOCK INSIGHT NEWSLETTER
6M Average Volume: 162,486 P/B: -29.23 NSE Code: PANACEABIO
52-Week Range: R 196.25 - 364.35 Dividend Yield: 0.00% BSE Code: 531349
TTM EPS: R -9.91 Book Value: R -7.43 Face Value: R 1
Price Graph
  • Laurus Labs (NSE)
  • NIFTY 50


Please wait while we are fetching data...
Get the best stock ideas
Want to create meaningful wealth through stock investing? Subscribe to Wealth Insight
Performance
  YTD 1-Month 3-Month 1-Year 3-Year 5-Year 10-Year
Panacea Biotec -7.98 -3.04 -15.06 -8.30 18.98 10.28 -0.58
NIFTY Smallcap 100* -20.30 -3.66 -4.22 -9.77 12.30 20.94 9.21
NIFTY Pharma* 8.79 7.96 12.30 12.05 -6.37 7.90 13.37
Company's return has been calculated on basis of NSE's price.
As on Sep 19, 2018
*As on Sep 18, 2018
Key Ratios
Revenue Per Share (R) Earnings Per Share (R) Return on Networth (%)


Please wait
while we are fetching data...


Please wait
while we are fetching data...


Please wait
while we are fetching data...
Annual Ratios (%)
  1-Year 3-Years 5-Years
Growth
Revenue -16.58 2.23 -5.16
Net Profit -189.83 13.54 11.19
EPS -252.43 12.53 11.02
Book Value -139.50 -191.26 -168.01
Average
Operating Margin 21.13 17.30 5.11
Net Margin -10.25 -9.22 -17.46
Return on Networth 0.00 -84.34 -80.19
Return on Investment 5.21 5.20 1.41
Interim Growth Ratios (%)
  QoQ YoY YTD
Quarterly
Revenue -43.24 -11.64 -44.62
Operating Profit -144.00 -149.50 -126.66
Net Profit -330.76 23.25 -68.94
EPS -330.76 23.25 -68.95
TTM
Revenue -2.16 7.84 4.30
Operating Profit -9.09 -5.94 -26.90
Net Profit 15.53 39.38 16.43
EPS 15.53 39.38 16.45
Peer Comparison
  Market Cap
(R Cr)
Revenue
(R Cr)
Net Profit
(R Cr)
Net Margin (%) RoE (%) Price to Book Price to Earnings
Panacea Biotec 1,329.75 567.40 -60.72 -10.34 0.00 -29.23 -
FDC 4,209.22 1,110.50 190.12 16.22 13.67 3.20 22.14
Laurus Labs 4,608.58 2,116.80 145.26 6.78 11.97 3.09 31.73
Insider Trades
Date Person  Buy / Sell Transaction
Type
No of Shares Price
(R)   
Value
(R Lakhs)
Sep 04, 2018 Rajesh Jain HUF  Sell Market 266,665 241.95 645.20
Sep 04, 2018 Rajesh Jain HUF  Sell Market 29,153 241.95 70.54
Apr 06, 2018 Ashwani Jain  Sell Market 21,360 303.55 64.84
Mar 28, 2018 Serum Institude Of India Pvt Ltd  Buy Open Market 320,137 267.15 855.25
Mar 19, 2018 Sunanda Jain  Buy Transmission 5,712,300 279.85 15,985.87
Fund Houses invested in the stock
Fund Mar-16 Dec-15 Sep-15 Jun-15 Mar-15
ICICI Prudential Mutual Fund 0.192 0.535 0.539 0.576 0.576
Figures given above are % of equity capital
Review & Analysis
News & Announcements
Contact Information

Company: Panacea Biotec Ltd.

Address: Ambala - Chandigarh Highway, Lalru, Punjab - 140501 | Phone: 01762- 505900 | Fax: 01762- 505909 / 505906

Email: investorgrievances@panaceabiotec.com

Website: www.panacea-biotec.com

Registrar & Transfer Agent: Skyline Financial Services Pvt Ltd

Address: D-153/A, 1st Floor,Okhla Industrial Area, Phase - I, New Delhi - 110020, D-153/A, 1st Floor, Okhla Industrial Area, Phase - I | Phone: 91-011-26812682/84 | Fax: 91-11-26292681

Email: admin@skylinerta.com

comments powered by Disqus
Essential checks
Altman Z-Score
1.12
Piotroski F-Score
4
Modified C-Score
4
5-Years Price to Earnings
Not applicable
5-Years Price to Book
-29.23
Earnings Yield
EBIT / Enterprise value
2.27%
PEG
Price / Earnings to growth ratio
Not available
Related Stocks
  Current Price   Chng %
Astrazeneca Pharma India R1,714.40 +2.30%
Caplin Point Laboratories R478.50 -3.22%
Dishman Carbogen Amcis R271.25 -2.11%
FDC R241.35 -0.52%
Granules India R111.65 0.00%
Laurus Labs R435.45 +0.39%
Merck R2,963.20 -4.16%
Shilpa Medicare R501.05 -1.34%
Strides Pharma Science R489.80 -1.69%
Suven Life Sciences R289.30 -4.13%
As on Sep 19, 15:59